Relationship between endothelial nitric oxide synthase (eNOS) and natural history of intracranial aneurysms: meta-analysis
Carregando...
Citações na Scopus
18
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGER
Autores
YAMAKI, Vitor Nagai
TEIXEIRA, Renan Kleber Costa
JONG-A-LIEM, Glaucia Suzanna
YAMADA, Elizabeth Sumi
RIBEIRO-DOS-SANTOS, Andrea
Citação
NEUROSURGICAL REVIEW, v.41, n.1, p.87-94, 2018
Resumo
The aneurysmal subarachnoid hemorrhage is a major public health problem described as a sudden drastic event with no warning symptoms and high morbidity and mortality rates. The role of the endothelial isoform of nitric oxide synthase gene polymorphism in intracranial aneurysms (IAs) is still a matter of controversy with divergent findings among European, American, and Asian populations. Our study purposed to test the association between intracranial aneurysms formation and nitric oxide gene polymorphisms through a systematic review and meta-analysis. Systematic search on Medline, Lilacs, and EMBASE was performed. The primary search resulted in 139 papers, out of which 9 met our inclusion criteria after a full text analysis. The dominant T786C model found a significant association with IA (OR 1.22, 95 % CI 1.04-1.44, p = 0.01), so did studies of the recessive T786C model (OR 0.37, 95 % CI 0.30-0.45, p < 0.0001) but with opposite effect. Our findings support the presence of the T786C polymorphism as a predictor for the development of intracranial aneurysm in the cerebral vascular system. More studies are necessary in order to elucidate the pathways of the endothelial nitric oxide synthase (eNOS) in cerebrovascular diseases and in defining how different allelic combinations of the eNOS gene single-nucleotide polymorphism (SNP) could favor this pathological process.
Palavras-chave
Endothelial nitric oxide synthase, Genetic polymorphisms, Intracranial aneurysms, Meta-analysis, Subarachnoid hemorrhage
Referências
- Akagawa H, 2005, J NEUROSURG, V102, P68, DOI 10.3171/jns.2005.102.1.0068
- Caranci F, 2013, EUR J RADIOL, V82, P1598, DOI 10.1016/j.ejrad.2012.12.026
- Chiang TM, 2001, THROMB RES, V102, P343, DOI 10.1016/S0049-3848(01)00252-3
- FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001
- Forget TR, 2001, NEUROSURGERY, V49, P1322, DOI 10.1097/00006123-200112000-00006
- GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081
- Gurjar MV, 1999, ARTERIOSCL THROM VAS, V19, P2871, DOI 10.1161/01.ATV.19.12.2871
- Guzik TJ, 2002, HYPERTENSION, V39, P1088, DOI 10.1161/01.HYP.0000018041.48432.B5
- Hingorani AD, 2003, CURR HYPERTENS REP, V5, P19, DOI 10.1007/s11906-003-0006-0
- INGALL TJ, 1989, STROKE, V20, P718, DOI 10.1161/01.STR.20.6.718
- Jellinger K, 1977, Zentralbl Neurochir, V38, P29
- Khurana VG, 1997, J CLIN NEUROSCI, V4, P122, DOI 10.1016/S0967-5868(97)90061-8
- Khurana VG, 2004, J CEREBR BLOOD F MET, V24, P291, DOI 10.1097/01.WCB.0000110540.96047.C7
- Khurana VG, 2003, STROKE, V34, P2555, DOI 10.1161/01.STR.0000096994.53810.59
- Khurana VG, 2002, STROKE, V33, P782, DOI 10.1161/hs0302.103735
- Kim TG, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS10227
- Ko NU, 2008, STROKE, V39, P1103, DOI 10.1161/STROKEAHA.107.496596
- Koshy L, 2008, DIS MARKERS, V24, P333, DOI 10.1155/2008/193590
- Kotani K, 2000, INTERNAL MED, V39, P537, DOI 10.2169/internalmedicine.39.537
- Krex D, 2006, J CEREBR BLOOD F MET, V26, P1250, DOI 10.1038/sj.jcbfm.9600284
- Krischek B, 2006, J NEUROSURG, V105, P717, DOI 10.3171/jns.2006.105.5.717
- Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399
- Lembo G, 2001, STROKE, V32, P735, DOI 10.1161/01.STR.32.3.735
- McColgan P, 2010, J NEUROSURG, V112, P714, DOI 10.3171/2009.8.JNS092
- MONCADA S, 1991, PHARMACOL REV, V43, P109
- Nahed BV, 2007, NEUROSURGERY, V60, P213, DOI 10.1227/01.NEU.0000249270.18698.BB
- Nakayama M, 1999, CIRCULATION, V99, P2864
- Ozum U, 2008, ACTA NEUROCHIR, V150, P57, DOI 10.1007/s00701-007-1467-8
- Peck G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003691
- Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002
- Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251
- Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699
- Song MK, 2006, J KOREAN MED SCI, V21, P922, DOI 10.3346/jkms.2006.21.5.922
- Starke RM, 2008, J CEREBR BLOOD F MET, V28, P1204, DOI 10.1038/jcbfm.2008.11
- SUNDT TM, 1978, NEW ENGL J MED, V299, P116, DOI 10.1056/NEJM197807202990303
- Wang XL, 2000, MOL GENET METAB, V70, P241, DOI 10.1006/mgme.2000.3033
- Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3